Stay updated on NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.

Latest updates to the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page
- Check6 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a platform or site release rather than any change to the clinical trial details.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedA new page revision v3.5.0 was added and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page header now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2, indicating a minor update. No changes to study details, eligibility criteria, or locations.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page shows a minor revision update: v3.4.1 was added and v3.4.0 was removed, with no visible changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.